Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease.
Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease. Proc Natl Acad Sci U S A. 2005 Aug 16; 102(33):11740-5.